Autsavapromporn, N.; Duangya, A.; Klunklin, P.; Chitapanarux, I.; Kranrod, C.; Jaikang, C.; Monum, T.; Tokonami, S.
Combined Serum IL-6 and CYFRA 21-1 as Potential Biomarkers for Radon-Associated Lung Cancer Risk: A Pilot Study. Biomedicines 2025, 13, 2145.
https://doi.org/10.3390/biomedicines13092145
AMA Style
Autsavapromporn N, Duangya A, Klunklin P, Chitapanarux I, Kranrod C, Jaikang C, Monum T, Tokonami S.
Combined Serum IL-6 and CYFRA 21-1 as Potential Biomarkers for Radon-Associated Lung Cancer Risk: A Pilot Study. Biomedicines. 2025; 13(9):2145.
https://doi.org/10.3390/biomedicines13092145
Chicago/Turabian Style
Autsavapromporn, Narongchai, Aphidet Duangya, Pitchayaponne Klunklin, Imjai Chitapanarux, Chutima Kranrod, Churdsak Jaikang, Tawachai Monum, and Shinji Tokonami.
2025. "Combined Serum IL-6 and CYFRA 21-1 as Potential Biomarkers for Radon-Associated Lung Cancer Risk: A Pilot Study" Biomedicines 13, no. 9: 2145.
https://doi.org/10.3390/biomedicines13092145
APA Style
Autsavapromporn, N., Duangya, A., Klunklin, P., Chitapanarux, I., Kranrod, C., Jaikang, C., Monum, T., & Tokonami, S.
(2025). Combined Serum IL-6 and CYFRA 21-1 as Potential Biomarkers for Radon-Associated Lung Cancer Risk: A Pilot Study. Biomedicines, 13(9), 2145.
https://doi.org/10.3390/biomedicines13092145
